Anaemia and neoadjuvant hormone therapy in radical surgery of localised prostate cancer;Anemia y hormonoterapia neoadyuvante en la cirugía radical del cáncer de próstata localizado

Actas Urologicas Espanolas

Volumn 25, Issue 2, 2001, Pages 105-109

  Arango Toro, O ^a   Lorente Garin J A ^a   Bielsa Gali, O ^a   Grino Garreta J ^a   Gelabert Mas, A ^a  

^a NONE   (Spain)

Author keywords

Anaemia; Localised prostate cancer; Maximum androgen blockade; Neoadjuvant hormone therapy; Radical surgery

Indexed keywords

ANDROGEN; ERYTHROPOIETIN; FLUTAMIDE; GONADORELIN DERIVATIVE; HEMOGLOBIN; LEUPRORELIN; TRIPTORELIN;

ANEMIA; ARTICLE; BONE MARROW CELL; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEMATOCRIT; HORMONAL THERAPY; HORMONE DEFICIENCY; HUMAN; MALE; PROSTATE CANCER; PROSTATECTOMY;

EID: 0035075913     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(01)72581-8     Document Type: Article

References (25)

1. Use of neoadjuvant androgen deprivation therapy in clinically localized prostate cancer
2. Downstagin by combination therapy with flutamide and LHRH agonist before radical prostatectomy
3. Neoadjuvant hormonal treatment prior to radical prostatectomy: Facts and open questions
4. Physiologic mechanism and the hematopoietic effects of androstanes and their derivatives
5. Hematologic effects of androgens revisites: An alternative therapy in various hematologic conditions
6. The role of testosterone secretion as indicated by the effect of castration in man and by studies of pathological conditions and the lifespan associated with maleness
7. The incidence of anemia in prostate cancer patients treated with androgen suppression and pelvic radiotherapy
8. Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade
9. Anaemia in men reciving combined finasteride and flutamide therapy for advanced prostate cancer
10. Anaemia in patients reciving neoadjuvant hormonotherapy prior to radical prostatectomy for localized cancer
11. Biological actions of androgens
12. Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive in men
13. Erithropoietin stimulates testosterone production in man
14. The effect of testosterone on erythropoietin levels in anemic patients
15. Erythropoietic response of dialized patients to testosterone administration
16. Tissue culture of bone marrow. II. Effect of steroid hormones on hematopoiesis in vivo
17. Erithropoietin: Pharmacology, biogenesis and control of production
18. Relación entre eritropoyesis, andrógenos y prostaglandinas
19. Anaemia of androgen deprivation (AAD) in patients receiving combination hormone blockade: Response to erythropoietin
20. Safety, side effects and patients acceptance of the luteinizing hormone relasing hormone agonist leuprolide in the treatment of benign prostatic hyperplasia
21. Experience with flutamide in patient with advanced prostate cancer without prior hormone therapy
22. Long-term experience with flutamude in patients with prostatic carcinoma
23. The effect of finasteride in meth benign prostatic hyperplasia
24. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: Flutamide versus diethylstillbestrol
25. Casodex™ 10-200 MG diarios, utilizados como monoterapia para el tratamiento de pacientes con cáncer de próstata avanzado